Boston Scientific Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $4.60B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $876.0M | 19.0% |
| Business Acquisitions | $1.59B | 34.6% |
| Other Investing | $171.0M | 3.7% |
| Other Financing | $395.0M | 8.6% |
| Working Capital | $25.0M | 0.5% |
| Net Cash Flow | $1.54B | 33.5% |